维普中文期刊产品整合服务
11篇 您的检索式:作者名="Maynard C."
    题名 作者 年代 出处 被引量
1Outcomes with Split Liver Transplantation Are Equivalent to Those with Whole Organ Transplantation显示文摘M.B. Majella Doyle Erin Maynard Yiing Lin Neeta Vachharajani Surendra Shenoy Christopher Anderson Mark Earl Jeffrey A. Lowell William C. Chapman 2013Journal of the American College of Surgeons2013,,1:2
2Angiogenic factors for the prediction of preeclampsia in high-risk women显示文摘Tiffany A. Moore Simas Sybil L. Crawford Matthew J. Solitro Sara C. Frost Bruce A. Meyer Sharon E. Maynard 2007American Journal of Obstetrics and Gynecology2007,,3:1
3Recurrent and persistent brown tide blooms perturb coastal marine ecosystem显示文摘Elizabeth M. Cosper William C. Dennison Edward J. Carpenter V. Monica Bricelj James G. Mitchell Susan H. Kuenstner David Colflesh Maynard Dewey 1987Estuaries1987,,4:1
4Predicting within-family variability in juvenile height growth of Salix based upon similarity among parental AFLP fingerprints显示文摘R. Kopp L. Smart C. Maynard G. Tuskan L. Abrahamson 2002Theoretical and Applied Genetics2002,,1:1
5The mitochondrial transcription factor A functions in mitochondrial base excision repair显示文摘Chandrika Canugovi Scott Maynard Anne-Cécile V. Bayne Peter Sykora Jingyan Tian Nadja C. de Souza-Pinto Deborah L. Croteau Vilhelm A. Bohr 2010DNA Repair2010,,10:1
6The electric field instrument on the polar satellite显示文摘P. Harvey F. S. Mozer D. Pankow J. Wygant N. C. Maynard H. Singer W. Sullivan P. B. Anderson R. Pfaff T. Aggson A. Pedersen C. -G. F?lthammar P. Tanskannen 1995Space Science Reviews (-)1995,,1:1
7Early results from ISEE-1 electric field measurements显示文摘J. P. Heppner N. C. Maynard T. L. Aggson 1978Space Science Reviews1978,,6:1
8The mitochondrial transcription factor A functions in mitochondrial base excision repair显示文摘Chandrika Canugovi Scott Maynard Anne-Cécile V. Bayne Peter Sykora Jingyan Tian Nadja C. de Souza-Pinto Deborah L. Croteau Vilhelm A. Bohr 2010DNA Repair2010,,10:1
9金刚烷胺三联疗法治疗无应答型丙型肝炎患者显示文摘Background/Aims: To determine whether addition of amantadine to pegylated interferon/ribavirin improved response rates among chronic hepatitis C patients, non-responders to interferon/ ribavirin and study the dynamic of response. Methods: In a double blind, multicenter, randomized trial, 200 non-responder patients received pegylated interferon 1.5 μ g/kg per week and ribavirin 800- 1200 mg/day, plus either amantadine 200 mg/day or placebo for 48 weeks. Endpoints were virological responses, ALT normalization, and histological benefit overtime. Results: Twenty percent of all patients achieved a sustained virological response (SVR). This rate was 8% higher in the triple therapy group (24% ) compared with the double therapy group (16% ) (P=0.22). A better virological response rate at week 24 was observed in the triple regimen group (43 vs 29% ; P=0.06), which was lost at week 48 suggesting viral escape. The biochemical response rate was also significantly higher with triple therapy at week 12 (63 vs 49% ; P=0.05) and week 24 (64 vs 49% ; P=0.03). Fibrosis stabilized or improved in 77% of all patients. Conclusions: Re-treatment of interferon/ ribavirin non-responder patients should be encouraged since a substantial proportion benefits from retreat-ment with pegylated interferon/ribavirin ± amantadine. In triple therapy involving amantadine, a time wise response and an increased SVR rate in subgroups less prone to viral breakthrough suggest clues for existing controversies.Maynard M. Pradat P. Bailly F. C. Trépo 孟欣颖(译) 王顺涛(校) 2006世界核心医学期刊文摘(胃肠病学分册)2006,2,8:1
10Liver Transplantation for Hepatocellular Carcinoma: Long-Term Results Suggest Excellent Outcomes显示文摘M.B. Majella Doyle Neeta Vachharajani Erin Maynard Surendra Shenoy Christopher Anderson Jason R. Wellen Jeffrey A. Lowell William C. Chapman 2012Journal of the American College of Surgeons2012,,1:1
11退伍军人卫生管理局药物洗脱支架使用现状Maynard C. Lowy E. Wagner T. Sales A. E. 操斌全 2005世界核心医学期刊文摘(心脏病学分册)2005,0,12:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费